During the past decade, Hopital Bretonneau; Hematologie Therapie Cellulaire conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bretonneau; Hematologie Therapie Cellulaire" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are "Multiple Myeloma" (2 trials), "Myelodysplastic Syndromes" (2 trials), "B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphocytic Leukemia (CLL)" (1 trials). Many other conditions were trialed in "Hopital Bretonneau; Hematologie Therapie Cellulaire" in a lesser frequency.

Most popular intervention types in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Fludarabine" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Bretonneau; Hematologie Therapie Cellulaire". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hopital Bretonneau; Hematologie Therapie Cellulaire, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bretonneau; Hematologie Therapie Cellulaire, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".